Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹120 Cr₹800 Cr₹1,814 Cr₹-2,969 Cr₹-1,365 Cr

What is the latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA ?

The latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA is ₹120 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹120 Cr
Mar2024₹800 Cr
Mar2023₹1,814 Cr
Mar2022₹-2,969 Cr
Mar2021₹-1,365 Cr

How is Cash Flow from Financing Activities of AUROBINDO PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹120 Cr
-85.04
Mar2024 ₹800 Cr
-55.89
Mar2023 ₹1,814 Cr
Positive
Mar2022 ₹-2,969 Cr
Negative
Mar2021 ₹-1,365 Cr -

Compare Cash Flow from Financing Activities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹86,977.7 Cr 1.3% 10.9% 28.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,735.0 Cr -0.6% 10.3% 4.5% Stock Analytics
DIVIS LABORATORIES ₹180,312.0 Cr 1.4% 11% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,369.0 Cr -1.5% 3.3% 37.6% Stock Analytics
CIPLA ₹107,205.0 Cr -2.6% 7.9% -13.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,592.0 Cr -3.2% 2.7% 10.6% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.3%

10.9%

28.5%

SENSEX

-4.3%

-2.6%

-7.6%


You may also like the below Video Courses